Weitere Artikel dieser Ausgabe durch Wischen aufrufen
There exists a German version of this article under DOI 10.1007/s00391-015-0959-z
Previous studies have indicated a relationship between type II diabetes (T2D), metabolic syndrome (MetS) and pulmonary function but the pathological mechanism responsible remains unclear. The aim of the current analysis within the Berlin Aging Study II (BASE-II) was to investigate the influence of abdominal obesity and muscle mass on pulmonary function in subjects with T2D and MetS.
A prebronchodilator pulmonary function test was carried out in 1369 subjects from the BASE-II (mean age 69 ± 4 years, 51.6 % women) where T2D was defined according to the German Diabetes Association (DDG) criteria, MetS according to the criteria of the International Diabetes Foundation (IDF), American Heart Association (AHA) and National Heart, Lung and Blood Institute (NHLBI) criteria from 2009 and pulmonary obstruction (obstructive lung disease, OLD) by the Global Initiative for Chronic Obstructive Lung Disease (GOLD) criteria of a forced expiratory volume in 1 s (FEV1 and forced vital capacity (FVC) ratio < 70 %.
Of the subjects 50.9 % achieved a sufficient level of quality according to the GOLD guidelines and were analyzed with respect to the research question. The FEV1 and FVC were decreased in study participants with T2D and MetS and the lung volume decreased with an increasing number of MetS criteria. Parameters of body composition, such as waist circumference and muscle mass had a significant influence on lung volumes, independent of MetS or T2D.
In this study MetS and T2D were associated with decreased lung volumes; however, muscle mass and abdominal obesity proved to be the most important factors influencing pulmonary function and could thus form the link between pulmonary function and MetS or T2D. Measurement of grip strength for the determination of muscle mass and waist circumference for determining abdominal obesity could contribute to the interpretation of the results of pulmonary function tests.
Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten
Sie möchten Zugang zu diesem Inhalt erhalten? Dann informieren Sie sich jetzt über unsere Produkte:
Alberti KG, Eckel RH, Grundy SM et al (2009) Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120:1640–1645 CrossRefPubMed
Arcari A, Magnacca S, Bracone F et al (2013) Relation between pulmonary function and 10-year risk for cardiovascular disease among healthy men and women in Italy: the Moli-sani Project. Euro J Prev Cardiol 20:862–871 CrossRef
Bertram L, Böckenhoff A, Demuth I et al (2013) Cohort profile: the Berlin Aging Study II (BASE-II). Int J Epidemiol 43:702.712
Engstrom G, Hedblad B, Janzon L et al (2000) Respiratory decline in smokers and ex-smokers–an independent risk factor for cardiovascular disease and death. J Cardiovasc Risk 7:267–272 PubMed
Ford ES, Cunningham TJ, Mercado CI (2014) Lung function and metabolic syndrome: Findings of National Health and Nutrition Examination Survey 2007–2010. J Diabetes 6:603–613 CrossRef
Jacobs DR Jr, Muldoon MF, Rastam L (1995) Invited commentary: low blood cholesterol, nonillness mortality, and other nonatherosclerotic disease mortality: a search for causes and confounders. Am J Epidemiol 141:518–522 PubMed
Kellerer M, Siegel E (2013) Praxisempfehlungen der Deutschen Diabetes Gesellschaft. Diabetologie 8(Suppl 2):S103
Rathmann W, Haastert B, Icks AA et al (2003) High prevalence of undiagnosed diabetes mellitus in Southern Germany: target populations for efficient screening. The KORA survey 2000. Diabetologia 46:182–189 PubMed
Schols AM, Broekhuizen R, Weling-Scheepers CA et al (2005) Body composition and mortality in chronic obstructive pulmonary disease. Am J Clin Nutr 82:53–59 PubMed
Sumner AD, Khalil YK, Reed JF (2012) The relationship of peripheral arterial disease and metabolic syndrome prevalence in asymptomatic US adults 40 years and older: results from the National Health and Nutrition Examination Survey (1999–2004). J Clin Hypertens 14:144–148 CrossRef
Lung function in elderly subjects with metabolic syndrome and type II diabetes
Data from the Berlin Aging Study II
Dr. Nikolaus Buchmann
- Springer Berlin Heidelberg
Zeitschrift für Gerontologie und Geriatrie
Print ISSN: 0948-6704
Elektronische ISSN: 1435-1269